Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Capricor Therap (CAPR)

Capricor Therap (CAPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
CAPR Stock Up on Completion of Rolling Submission of DMD Drug BLA
CAPR Stock Up on Completion of Rolling Submission of DMD Drug BLA Zacks Investment Research - Fri Jan 3, 10:50AM CST

Shares of Capricor Therapeutics CAPR gained 8.4% on Thursday following the completion of the submission of a biologics license application (BLA) to the FDA seeking full approval for deramiocel to treat...

CTMX : 0.8911 (+2.68%)
CSTL : 26.44 (-0.23%)
SPRO : 0.8677 (-0.36%)
CAPR : 14.80 (+1.86%)
Capricor Therapeutics Stock Surges On BLA Submission for Cell Therapy To Treat Muscular Dystrophy: Retail’s Excited Stocktwits - Fri Jan 3, 2:56AM CST

Deramiocel is an investigational cell therapy aimed at treating patients diagnosed with Duchenne muscular dystrophy (DMD) cardiomyopathy.

IWN : 168.28 (+0.05%)
VTI : 301.30 (-0.29%)
IWM : 228.69 (-0.28%)
CAPR : 14.80 (+1.86%)
Capricor Therapeutics Completes Submission of Biologics License Application to the U.S. FDA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy GlobeNewswire - Thu Jan 2, 8:15AM CST

CAPR : 14.80 (+1.86%)
Capricor Therapeutics to Present at Piper Sandler and Oppenheimer Investor Conferences in December 2024 Quiver Quantitative, Inc. - Tue Dec 3, 2024

Capricor Therapeutics announces presentations at upcoming investor conferences regarding its exosome-based therapeutics and clinical developments.Quiver AI SummaryCapricor Therapeutics announced its participation...

CAPR : 14.80 (+1.86%)
Capricor Therapeutics to Present at Upcoming Investor Conferences GlobeNewswire - Mon Dec 2, 2024

CAPR : 14.80 (+1.86%)
Capricor Therapeutics Granted Orphan Drug and ATMP Status for Deramiocel by European Medicines Agency GlobeNewswire - Wed Nov 20, 2024

CAPR : 14.80 (+1.86%)
Capricor: Q3 Earnings Snapshot AP - Wed Nov 13, 2024

Capricor: Q3 Earnings Snapshot

CAPR : 14.80 (+1.86%)
Capricor Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update GlobeNewswire - Wed Nov 13, 2024

CAPR : 14.80 (+1.86%)
Capricor Therapeutics to Present Exosome Platform Updates at 2024 American Association of Extracellular Vesicles Annual Meeting GlobeNewswire - Tue Nov 12, 2024

CAPR : 14.80 (+1.86%)
Capricor Therapeutics to Present Third Quarter 2024 Financial Results and Recent Corporate Update on November 13 GlobeNewswire - Tue Nov 5, 2024

CAPR : 14.80 (+1.86%)

Barchart Exclusives

3 Dividend Powerhouses To Buy and Hold Amid Market Uncertainty Barchart - Fri Jan 24, 6:00PM CST
Dividend stocks provide steady income, balancing market uncertainty. These three companies are a great place to start. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot